Inflammatory marker levels and prediction of patient-reported symptoms in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy. This is an ASCO Meeting Abstract from the ...

Cachexia is a metabolic disorder characterised by muscle wasting, diminished response to anti-cancer treatments and poor quality of life. Our objective was to identify blood-based biomarkers of ...

Cachexia causes extreme weight loss and muscle wasting. It is a symptom of various chronic conditions such as cancer, chronic renal failure, HIV, and multiple sclerosis. Cachexia predominantly affects ...

Primary prevention of venous thromboembolic events (VTE) in cancer patients: An American survey study This is an ASCO Meeting Abstract from the 2004 ASCO Annual Meeting. This abstract does not include ...

Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...

Weight loss and heart failure share a connection. People living with heart failure may experience unexpected and extreme weight loss, known as cardiac cachexia. When weight loss occurs with heart ...

Communicating with family members about cachexia and anorexia can be difficult. "I tell patients' families to gently encourage but don't try to force feed, because that is actually worse than doing ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...

Ponsegromab treatment led to sustained weight gain and GDF-15 suppression over 64 weeks in cancer-associated cachexia patients. Patients initially on placebo gained weight after switching to ...